Pelabresib in combination with ruxolitinib for Janus Kinase inhibitor treatment-naïve patients with myelofibrosis: Results of the MANIFEST-2 randomized, double-blind, phase 3 study Meeting Abstract
| Authors: | Rampal, R. K.; Grosicki, S.; Chraniuk, D.; Abruzzese, E.; Bose, P.; Gerds, A. T.; Vannucchi, A. M.; Palandri, F.; Lee, S. E.; Gupta, V.; Lucchesi, A.; Oh, S. T.; Kuykendall, A. T.; Patriarca, A.; Alvarez-Larran, A.; Mesa, R.; Kiladjian, J. J.; Talpaz, M.; Harris, M.; Kays, S. K.; Jegg, A. M.; Li, Q.; Brown, B.; Harrison, C. N.; Mascarenhas, J. |
| Abstract Title: | Pelabresib in combination with ruxolitinib for Janus Kinase inhibitor treatment-naïve patients with myelofibrosis: Results of the MANIFEST-2 randomized, double-blind, phase 3 study |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 628 |
| Language: | English |
| ACCESSION: | WOS:001159306702141 |
| DOI: | 10.1182/blood-2023-179141 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
